touchPODCAST

Accurately diagnosing severe type 2 asthma in children

touchMDT for touchRESPIRATORY

Listen to key experts from a multidisciplinary team and a patient advocate discuss the diagnosis of severe asthma in children, and the use of biomarkers to support decisions.

The multidisciplinary team:

• Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK
• Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA
• Primary care physician: Dr Ioanna Tsiligianni, University of Crete, Crete, Greece
• Patient advocate: Ms Monique Cooper, Miami, FL, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Sanofi and  Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information please visit: https://touchrespiratoryime.org/mdt-severe-paediatric-asthma

Accurately diagnosing severe type 2 asthma in children

touchMDT for touchIMMUNOLOGY

Listen to key experts from a multidisciplinary team and a patient advocate discuss the diagnosis of severe asthma in children, and the use of biomarkers to support decisions.

The multidisciplinary team:

• Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK
• Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA
• Primary care physician: Dr Ioanna Tsiligianni, University of Crete, Crete, Greece
• Patient advocate: Ms Monique Cooper, Miami, FL, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information please visit: https://touchimmunologyime.org/mdt-severe-paediatric-asthma

MDT perspectives on the current and emerging second-line treatment options for SCLC

touchMDT for touchRESPIRATORY

Listen to key experts from a multidisciplinary team discuss the second-line treatment choices for patients with relapsed SCLC and highlight key emerging treatments and combinations in the second-line setting.

The multidisciplinary team:

• Medical oncologist: Dr Barbara Melosky, University of British Columbia, Vancouver, Canada
• Oncology pharmacist: Dr Sonia Amin Thomas, Wellstar North Fulton Hospital and Northwest Georgia Oncology Center, Roswell, GA, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information please visit: https://www.touchrespiratory.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/

MDT perspectives on managing side effects associated with second-line treatment for SCLC

touchMDT for touchRESPIRATORY

Listen to key experts from a multidisciplinary team discuss the management strategies for patients with relapsed SCLC experiencing treatment side effects and consider how to balance clinical effectiveness with patient quality of life

The multidisciplinary team:

• Medical oncologist: Dr Barbara Melosky, University of British Columbia, Vancouver, Canada
• Oncology nurse practitioner: Dr Victoria Sherry, Abramson Cancer Center, Hospital of the University of Pennsylvania, PA, USA
• Oncology pharmacist: Dr Sonia Amin Thomas, Wellstar North Fulton Hospital and Northwest Georgia Oncology Center, Roswell, GA, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchrespiratoryime.org/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/ 

MDT perspectives on tailoring second-line treatment selection to each patient with relapsed SCLC

Listen to key experts from a multidisciplinary team discuss how side effects of SCLC treatment and patient performance status impact treatment selection and prognosis, and the potential for molecular classification to determine future treatment options

 The multidisciplinary team

• Medical oncologist: Dr Barbara Melosky, British Columbia, Canada
• Pulmonologist: Dr Christine Argento, Maryland, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://www.touchrespiratory.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/

MDT perspectives on managing side effects associated with second-line treatment for SCLC

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the management strategies for patients with relapsed SCLC experiencing treatment side effects and consider how to balance clinical effectiveness with patient quality of life

The multidisciplinary team:

• Medical oncologist: Dr Barbara Melosky, University of British Columbia, Vancouver, Canada
• Oncology nurse practitioner: Dr Victoria Sherry, Abramson Cancer Center, Hospital of the University of Pennsylvania, PA, USA
• Oncology pharmacist: Dr Sonia Amin Thomas, Wellstar North Fulton Hospital and Northwest Georgia Oncology Center, Roswell, GA, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME

For further information visit our website: https://touchoncology.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/

MDT perspectives on tailoring second-line treatment selection to each patient with relapsed SCLC

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team discuss how side effects of SCLC treatment and patient performance status impact treatment selection and prognosis, and the potential for molecular classification to determine future treatment options

 The multidisciplinary team:

• Medical oncologist: Dr Barbara Melosky, University of British Columbia, Vancouver, Canada
• Pulmonologist: Dr Christine Argento, Johns Hopkins University, Baltimore, MD

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncology.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/

 

MDT perspectives on the current and emerging second-line treatment options for SCLC

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team discuss the second-line treatment choices for patients with relapsed SCLC and highlight key emerging treatments and combinations in the second-line setting

The multidisciplinary team:

• Medical oncologist: Dr Barbara Melosky, University of British Columbia, Vancouver, Canada
• Oncology pharmacist: Dr Sonia Amin Thomas, Wellstar North Fulton Hospital and Northwest Georgia Oncology Center, Roswell, GA, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncology.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/

 

A patient’s perspective: Best practice for shared decision making in the prevention and treatment of migraine

touchIN CONVERSATION for touchNEUROLOGY

Listen to a migraine specialist and a patient advocate discuss the burden of migraine and the importance of shared decision making in meeting patient-oriented goals.

The discussion is stimulated by questions posed by healthcare professionals involved in the management of migraine. 

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Eli Lilly and Company. This activity is provided by touchIME.

For further information visit our website:
www.touchneurology.com

Optimizing outcomes for patients with Alzheimer’s disease: A focus on transdermal therapy

touchIN CONVERSATION for touchNEUROLOGY

Listen to a world-renowned expert in Alzheimer’s disease, Professor George Grossberg, and an active Alzheimer’s caregiver advocate, Ms Susan Miller, discuss their insights and experiences on  overcoming barriers to diagnosis and addressing symptomatic treatment needs through effective treatment choices and shared-management approaches.

The discussion is stimulated by real-world questions posed by healthcare professionals involved in the management of Alzheimer’s disease. 

This touchPODCAST is for healthcare professionals only. 

This activity is funded by an independent medical education grant from Corium Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://www.touchneurology.com